Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by enriquesuaveon Jul 06, 2021 12:38pm
193 Views
Post# 33499274

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Patient #16, #17 & #18

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Patient #16, #17 & #18

Even if they get 5 on 8 that would be great plus the 2 from PH1, that would be like 7 out 10 patients who got optimized procedure.  That would confirm a high efficacy for the market to understand what's going on here. All IMHO 


StevenBirch wrote: Don't you guys think we should wait for the next update, less than a month, before assuming that no more US patients have been treated? I understand the frustration but it is obvious now that the AGM was not going to reveal anything that we didn't already know.

Besides, and maybe I missed it previously but I thought they needed a minimum of 25 treated and now it seems like 20 - 25 so we are already there. Now only 8 have been treated with the optimized procedure but what if they go 7 for 8? Finding that out isn't that far away.

It can be depressing seeing the frustration here but isn't there something between $0.25 and an eventual buyout? Shouldn't we see a significant bounce within weeks or months if the results are what we expect?

 

<< Previous
Bullboard Posts
Next >>